| |
| |
|
| Insider
Information: |
Miller Joseph M |
| Relationship: |
Chief Financial Officer |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
536,510 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,452,461 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
536,510 |
|
|
| Total
Value |
$2,452,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-3.0
|
| Percentage
Gain/Loss : |
 48.4%
|
 -79.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avalo Therapeutics, Inc |
AVTX |
Director |
2020-06-08 |
40,582 |
2018-07-12 |
0 |
Premium* |
|
|
Aurinia Pharmaceuticals Inc |
AUPH |
Chief Financial Officer |
2024-03-06 |
495,928 |
2021-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AUPH |
Aurinia Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2024-03-06 |
4 |
S |
$5.60 |
$194,942 |
D/D |
(34,811) |
495,928 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2024-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
196,153 |
530,739 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2023-03-02 |
4/A |
S |
$8.78 |
$100,074 |
D/D |
(11,398) |
331,112 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
S |
$8.94 |
$100,986 |
D/D |
(11,296) |
331,214 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
229,421 |
342,510 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2022-03-02 |
4 |
S |
$12.01 |
$36,751 |
D/D |
(3,060) |
6,610 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,500 |
9,670 |
0 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2021-05-11 |
4 |
B |
$9.74 |
$9,740 |
D/D |
1,000 |
1,000 |
2.74 |
% |
|
| AVTX |
Avalo Therapeutics, Inc |
Director |
– • – |
2020-06-08 |
4 |
D |
$3.22 |
$14,400 |
D/D |
(4,472) |
40,582 |
0 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Financial Officer |
• – – |
2019-12-10 |
4 |
B |
$2.85 |
$7,398 |
D/D |
2,598 |
48,777 |
2.74 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Financial Officer |
• – – |
2019-06-10 |
4 |
B |
$2.85 |
$3,357 |
D/D |
1,179 |
46,179 |
2.66 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Financial Officer |
• – – |
2019-06-07 |
4 |
D |
$4.85 |
$18,057 |
D/D |
(3,723) |
45,054 |
0 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Chief Financial Officer |
• – – |
2018-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
45,000 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
